CRESCENT BIOPHARMA, INC. Operating Lease, Weighted Average Discount Rate, Percent
CRESCENT BIOPHARMA, INC. (CBIO) had Operating Lease, Weighted Average Discount Rate, Percent of 10.00% as of 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2025-02-13
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.00%.
- 2024-09-30: Operating Lease, Weighted Average Discount Rate, Percent 10.00%.
- 2024-06-30: Operating Lease, Weighted Average Discount Rate, Percent 10.00%.
- 2024-03-31: Operating Lease, Weighted Average Discount Rate, Percent 10.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2024-12-31 | 10.00% 10-K · filed 2025-02-13 |
| 2024-09-30 | 10.00% 10-Q · filed 2024-11-13 |
| 2024-06-30 | 10.00% 10-Q · filed 2024-08-08 |
| 2024-03-31 | 10.00% 10-Q · filed 2024-05-09 |
| 2023-12-31 | 10.00% 10-K · filed 2025-02-13 |
| 2023-09-30 | 9.90% 10-Q · filed 2023-11-03 |
| 2023-06-30 | 9.80% 10-Q · filed 2023-08-02 |
| 2022-12-31 | 8.00% 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |